Atlas Trials

A Study of CM310 in Children Patients With Moderate-to-severe Atopic Dermatis

Clinical trial NCT05579925 · COMPLETED

Trial details

NCT number
NCT05579925
Sponsor
Keymed Biosciences Co.Ltd
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Atopic Dermatitis
Start date
2022-10-07
Primary completion
2023-07-28
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.